This message was posted by a user wishing to remain anonymous
Hi Colleagues,
I am developing a regulatory plan for our IVD product. The whole IVD test system includes a few components(instruments) and lab processes. In 510(K) or De Novo submission, what are the requirements for those lab processes? The lab processes are oversight under CLIA regulations. What data FDA wants to see?
Thanks in advance.